Fate Therapeutics Inc. buy BiotechBee
Start price
26.10.22
/
70%
€20.67
Target price
31.12.24
€35.00
Performance (%)
-41.33%
End price
21.12.22
€12.12
Summary
This prediction ended on 21.12.22 with a price of €12.12. The BUY prediction by BiotechBee for Fate Therapeutics Inc. performed very badly with a performance of -41.33%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Fate Therapeutics Inc. | -9.435% | -9.435% | 20.016% | -79.286% |
| iShares Core DAX® | -1,10 % | -6,08 % | 3,20 % | 53,31 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % | 20,24 % | 93,48 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % | 27,55 % | 52,32 % |
| iShares S&P 500 | -0,06 % | 0,88 % | 14,89 % | 66,74 % |
According to BiotechBee what are the pros and cons of Fate Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Buy mit Kursziel 35,0